Page breadcrumb nav

VAERS Report 2136765

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Male

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: ex7823


Date de réception du rapport
2022-02-24
Date à laquelle le formulaire est complèté
Date de vaccination
2021-05-16
Date d’apparition
69
Nombre de jours (date d’apparition – date de vaccination)
69
Description de l’événement indésirable

two times a pneumonia; bronchitis; malaise; chills; pyrexia; this is a spontaneous report received from a contactable reporter (consumer or other non hcp) from the regulatory authority. the reporter is the patient. regulatory number: nl-lrb-00782905. a 70-year-old male patient received bnt162b2 (comirnaty), administration date 16may2021 (lot number: ex7823) as dose 2, single for covid-19 immunisation. relevant medical history included: "minor 'flu-like' symptoms" (unspecified if ongoing). concomitant medication included: pneumovax 23 taken for pneumococcal immunisation, administration date 23nov2021. vaccination history included: comirnaty (dose 1, 0.3 ml), administration date: 11apr2021, for covid-19 immunisation. the following information was reported: pneumonia (hospitalization) with onset 24jul2021, outcome "recovering", described as "two times a pneumonia"; pyrexia (non-serious) with onset 24jul2021, outcome "recovering", described as "pyrexia"; bronchitis (non-serious) with onset oct2021, outcome "not recovered", described as "bronchitis"; malaise (non-serious) with onset 24jul2021, outcome "recovering", described as "malaise"; chills (non-serious) with onset 24jul2021, outcome "recovering", described as "chills". the events "two times a pneumonia", "pyrexia", "bronchitis", "malaise" and "chills" were evaluated at the physician office visit. the patient underwent the following laboratory tests and procedures: body temperature: (24jul2021) 38 to 40.5; sars-cov-2 test: (jul2021) negative. therapeutic measures were taken as a result of pneumonia, pyrexia, bronchitis, malaise, chills and included treatment with oxygen, antibiotics and potassium. clinical course: patient with bronchitis, chills, malaise, pyrexia, and two times a pneumonia (caused or prolonged hospitalization) following administration of bnt162b2 (action taken: not applicable) for covid 19 immunisation. the recurrence happened in oct2021, with hospitalization and outcome: recovering/resolving. treatment: oxygen, antibiotics and potassium administration. patient was 70 years old; except for minor 'flu-lyke' symptoms never bothered; after pfizer 2 x pneumonia, prolonged bronchitis from late oct2021 until now (23jan2022); general practitioner asked if it could all be a result of the vaccinations. answer: 'no idea; who knows'. no follow-up attempts are possible. no further information is expected

Données de laboratoire
test date: 20210724; test name: pyrexia; result unstructured data: test result:38 to 40.5 centigrade; test date: 202107; test name: covid 19 pcr test; test result: negative
Liste des symptômes
chills malaise pyrexia pneumonia bronchitis sars-cov-2 test body temperature
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Oui
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na